
The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.
Pfizer Inc said on Friday it signed a multi-year agreement with Gilead Sciences Inc to manufacture and supply the company's antiviral drug remdesivir for COVID-19 patients.
The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.
First Published on Aug 7, 2020 06:07 pm
Read Again https://www.moneycontrol.com/news/trends/health-trends/pfizer-signs-deal-to-manufacture-and-supply-gileads-remdesivir-for-covid-19-treatment-5661431.htmlBagikan Berita Ini
0 Response to "Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment - Moneycontrol"
Post a Comment